PMID- 24387626 OWN - NLM STAT- MEDLINE DCOM- 20141021 LR - 20240117 IS - 1532-429X (Electronic) IS - 1097-6647 (Print) IS - 1097-6647 (Linking) VI - 16 IP - 1 DP - 2014 Jan 4 TI - T1-mapping in the heart: accuracy and precision. PG - 2 LID - 10.1186/1532-429X-16-2 [doi] AB - The longitudinal relaxation time constant (T1) of the myocardium is altered in various disease states due to increased water content or other changes to the local molecular environment. Changes in both native T1 and T1 following administration of gadolinium (Gd) based contrast agents are considered important biomarkers and multiple methods have been suggested for quantifying myocardial T1 in vivo. Characterization of the native T1 of myocardial tissue may be used to detect and assess various cardiomyopathies while measurement of T1 with extracellular Gd based contrast agents provides additional information about the extracellular volume (ECV) fraction. The latter is particularly valuable for more diffuse diseases that are more challenging to detect using conventional late gadolinium enhancement (LGE). Both T1 and ECV measures have been shown to have important prognostic significance. T1-mapping has the potential to detect and quantify diffuse fibrosis at an early stage provided that the measurements have adequate reproducibility. Inversion recovery methods such as MOLLI have excellent precision and are highly reproducible when using tightly controlled protocols. The MOLLI method is widely available and is relatively mature. The accuracy of inversion recovery techniques is affected significantly by magnetization transfer (MT). Despite this, the estimate of apparent T1 using inversion recovery is a sensitive measure, which has been demonstrated to be a useful tool in characterizing tissue and discriminating disease. Saturation recovery methods have the potential to provide a more accurate measurement of T1 that is less sensitive to MT as well as other factors. Saturation recovery techniques are, however, noisier and somewhat more artifact prone and have not demonstrated the same level of reproducibility at this point in time.This review article focuses on the technical aspects of key T1-mapping methods and imaging protocols and describes their limitations including the factors that influence their accuracy, precision, and reproducibility. FAU - Kellman, Peter AU - Kellman P AD - National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. kellman@nih.gov. FAU - Hansen, Michael S AU - Hansen MS LA - eng PT - Journal Article PT - Review DEP - 20140104 PL - England TA - J Cardiovasc Magn Reson JT - Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance JID - 9815616 RN - 0 (Contrast Media) SB - IM MH - Artifacts MH - Cardiomyopathies/*diagnosis/pathology/physiopathology MH - *Contrast Media MH - Fibrosis MH - Heart Rate MH - Humans MH - *Magnetic Resonance Imaging MH - *Myocardial Contraction MH - Myocardium/*pathology MH - Predictive Value of Tests MH - Prognosis MH - Reproducibility of Results MH - Severity of Illness Index MH - *Ventricular Function PMC - PMC3927683 EDAT- 2014/01/07 06:00 MHDA- 2014/10/22 06:00 PMCR- 2014/01/04 CRDT- 2014/01/07 06:00 PHST- 2013/11/28 00:00 [received] PHST- 2013/12/24 00:00 [accepted] PHST- 2014/01/07 06:00 [entrez] PHST- 2014/01/07 06:00 [pubmed] PHST- 2014/10/22 06:00 [medline] PHST- 2014/01/04 00:00 [pmc-release] AID - S1097-6647(23)00093-5 [pii] AID - 1532-429X-16-2 [pii] AID - 10.1186/1532-429X-16-2 [doi] PST - epublish SO - J Cardiovasc Magn Reson. 2014 Jan 4;16(1):2. doi: 10.1186/1532-429X-16-2.